Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Nikolaos Pyrpyris, Kyriakos Dimitriadis, Eirini Beneki, Panagiotis Iliakis, Stergios Soulaidopoulos, Panagiotis Tsioufis, Elena Adamopoulou, Alexandros Kasiakogias, Athanasios Sakalidis, George Koutsopoulos, Konstantina Aggeli & Konstantinos Tsioufis. (2024) LOX-1 Receptor: A Diagnostic Tool and Therapeutic Target in Atherogenesis. Current Problems in Cardiology 49:1, pages 102117.
Crossref
Crossref
Barnaby W.R. Roper, Christian Tiede, Izma Abdul-Zani, Gary A. Cuthbert, Dhananjay Jade, Ahmed Al-Aufi, William R. Critchley, Queen Saikia, Shervanthi Homer-Vanniasinkam, Tatsuya Sawamura, Michael J. McPherson, Michael A. Harrison, Darren C. Tomlinson & Sreenivasan Ponnambalam. (2023) “Affimer” synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation. Journal of Biological Chemistry 299:11, pages 105325.
Crossref
Crossref
Mohd Azeem Khan, Irshad Mohammad, Sohom Banerjee, Akanksha Tomar, Kottayil I Varughese, Jawahar L Mehta, Anmol Chandele & Arulandu Arockiasamy. (2023) Oxidized LDL receptors: a recent update. Current Opinion in Lipidology 34:4, pages 147-155.
Crossref
Crossref
Felix Duprat, Catalina Robles, María Paz Castillo, Yerko Rivas, Marcela Mondaca, Nery Jara, Francisco Roa, Romina Bertinat, Jorge Toledo, Cristian Paz & Iván González-Chavarría. (2023) LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects. International Journal of Molecular Sciences 24:6, pages 5082.
Crossref
Crossref
Gabrielle A. Dillon, Anna E. Stanhewicz, Corinna Serviente, Valerie A. Flores, Nina Stachenfeld & Lacy M. Alexander. (2022) Seven days of statin treatment improves nitric-oxide mediated endothelial-dependent cutaneous microvascular function in women with endometriosis. Microvascular Research 144, pages 104421.
Crossref
Crossref
Akanksha Tomar, Sibasis Sahoo, Muthusankar Aathi, Shobhan Kuila, Mohd Azeem Khan, Guru Raj Rao Ravi, Jeyakanthan Jeyaraman, Jawahar L. Mehta, Kottayil I. Varughese & Arulandu Arockiasamy. (2022) Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis. Biochemical and Biophysical Research Communications 623, pages 59-65.
Crossref
Crossref
Ali Mahmoudi, Sahar Heydari, Yuliya V. Markina, George E. Barreto & Amirhossein Sahebkar. (2022) Role of statins in regulating molecular pathways following traumatic brain injury: A system pharmacology study. Biomedicine & Pharmacotherapy 153, pages 113304.
Crossref
Crossref
Camila Reyes, Estefanía Nova-Lamperti, Daniel Duran-Sandoval, Daniela Rojas, Jorge Gajardo, Enrique Guzman-Gutierrez, Camila Bustos-Ruiz, Valeska Ormazábal, Felipe A. Zúñiga, Carlos Escudero & Claudio Aguayo. (2022) Loxin Reduced the Inflammatory Response in the Liver and the Aortic Fatty Streak Formation in Mice Fed with a High-Fat Diet. International Journal of Molecular Sciences 23:13, pages 7329.
Crossref
Crossref
Rajshekhar A Kore, Ashim K Bagchi, Kottayil I Varughese & Jawahar L Mehta. (2022) The structural basis of effective LOX-1 inhibition. Future Medicinal Chemistry 14:10, pages 731-743.
Crossref
Crossref
Qing Li, Chang Liu, Liang Deng, Enrui Xie, Nishant Yadav, Yuanyuan Tie, Zheng Cheng & Jie Deng. (2021) Novel function of fluvastatin in attenuating oxidized low‑density lipoprotein‑induced endothelial cell ferroptosis in a glutathione peroxidase4‑ and cystine‑glutamate antiporter‑dependent manner. Experimental and Therapeutic Medicine 22:5.
Crossref
Crossref
Alexander Akhmedov, Tatsuya Sawamura, Chu-Huang Chen, Simon Kraler, Daria Vdovenko & Thomas F Lüscher. (2021) Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease. European Heart Journal 42:18, pages 1797-1807.
Crossref
Crossref
Jonas Groner, Achim Goepferich & Miriam Breunig. (2021) Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology – A new chance for causative therapy?. Journal of Controlled Release 333, pages 536-559.
Crossref
Crossref
Joaquim BarretoSotirios K. KarathanasisAlan RemaleyAndrei C. Sposito. (2020) Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor. Arteriosclerosis, Thrombosis, and Vascular Biology.
Crossref
Crossref
Gary A. Cuthbert, Faheem Shaik, Michael A. Harrison, Sreenivasan Ponnambalam & Shervanthi Homer-Vanniasinkam. (2020) Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease. Cells 9:11, pages 2453.
Crossref
Crossref
Ju Hu, Jin Wang, Qing-xia Gan, Qian Ran, Guan-hua Lou, Hai-jun Xiong, Cheng-yi Peng, Ji-lin Sun, Ren-chuan Yao & Qin-wan Huang. (2020) Impact of Red Yeast Rice on Metabolic Diseases: A Review of Possible Mechanisms of Action. Journal of Agricultural and Food Chemistry 68:39, pages 10441-10455.
Crossref
Crossref
Gisela Schnapp, Heike Neubauer, Frank H. Büttner, Sandra Handschuh, Iain Lingard, Ralf Heilker, Klaus Klinder, Jürgen Prestle, Rainer Walter, Michael Wolff, Markus Zeeb, Francois Debaene, Herbert Nar & Dennis Fiegen. (2020) A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer state. Communications Chemistry 3:1.
Crossref
Crossref
Saadiya Zia, Sidra Batool & Ramla Shahid. (2020) Could PCSK9 be a new therapeutic target of Eugenol? In vitro and in silico evaluation of hypothesis. Medical Hypotheses 136, pages 109513.
Crossref
Crossref
Abhilasha Singh, Ashok Kumar Srinivasan, Lakshmi Narasimhan Chakrapani & Periandavan Kalaiselvi. (2019) LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline. Oxidative Medicine and Cellular Longevity 2019, pages 1-11.
Crossref
Crossref
Sanjiv Singh & Avtar Singh Gautam. (2019) Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis. Current Atherosclerosis Reports 21:10.
Crossref
Crossref
Sofia Raniolo, Stefano Croce, Rasmus P. Thomsen, Anders H. Okholm, Valeria Unida, Federico Iacovelli, Antonio Manetto, Jørgen Kjems, Alessandro Desideri & Silvia Biocca. (2019) Cellular uptake of covalent and non-covalent DNA nanostructures with different sizes and geometries. Nanoscale 11:22, pages 10808-10818.
Crossref
Crossref
Kunming Tian, Sayoko Ogura, Peter J. Little, Suo‐wen Xu & Tatsuya Sawamura. (2018) Targeting LOX‐1 in atherosclerosis and vasculopathy: current knowledge and future perspectives. Annals of the New York Academy of Sciences 1443:1, pages 34-53.
Crossref
Crossref
Sabina Pucci, Chiara Polidoro, Chiara Greggi, Francesca Amati, Elena Morini, Michela Murdocca, Michela Biancolella, Augusto Orlandi, Federica Sangiuolo & Giuseppe Novelli. (2019) Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes. Cell Death & Disease 10:2.
Crossref
Crossref
Gordon D. Brown, Janet A. Willment & Lauren Whitehead. (2018) C-type lectins in immunity and homeostasis. Nature Reviews Immunology 18:6, pages 374-389.
Crossref
Crossref
Silvana Balzan & Valter Lubrano. (2018) LOX-1 receptor: A potential link in atherosclerosis and cancer. Life Sciences 198, pages 79-86.
Crossref
Crossref
Federico Iacovelli, Fabio Giovanni Tucci, Gabriele Macari & Mattia Falconi. (2017) Multiple molecular dynamics simulations of human LOX-1 and Trp150Ala mutant reveal the structural determinants causing the full deactivation of the receptor. Proteins: Structure, Function, and Bioinformatics 85:10, pages 1902-1912.
Crossref
Crossref
Valentina BrunoBarbara RizzacasaAdalgisa PietropolliMaria Vittoria CapognaRenato MassoudCarlo TicconiEmilio PiccioneClaudio CorteseGiuseppe NovelliFrancesca Amati. (2017)
OLR1
and
Loxin
Expression in PBMCs of Women with a History of Unexplained Recurrent Miscarriage: A Pilot Study
. Genetic Testing and Molecular Biomarkers 21:6, pages 363-372.
Crossref
Crossref
C. Caliceti, P. Rizzo, R. Ferrari, F. Fortini, G. Aquila, E. Leoncini, L. Zambonin, B. Rizzo, D. Calabria, P. Simoni, M. Mirasoli, M. Guardigli, S. Hrelia, A. Roda & A.F.G. Cicero. (2017) Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin. Nutrition, Metabolism and Cardiovascular Diseases 27:6, pages 552-563.
Crossref
Crossref
Barbara Rizzacasa, Elena Morini, Sabina Pucci, Michela Murdocca, Giuseppe Novelli & Francesca Amati. (2017) LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies. International Journal of Molecular Sciences 18:2, pages 290.
Crossref
Crossref
Sofia Raniolo, Giulia Vindigni & Silvia Biocca. (2016) Cholesterol level regulates lectin-like oxidized low-density lipoprotein receptor-1 function. Biomedical Spectroscopy and Imaging 5:s1, pages S87-S99.
Crossref
Crossref
Li Qin, Neng Zhu, Bao-Xue Ao, Chan Liu, Ya-Ning Shi, Ke Du, Jian-Xiong Chen, Xi-Long Zheng & Duan-Fang Liao. (2016) Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis. International Journal of Molecular Sciences 17:3, pages 429.
Crossref
Crossref
Shraddha Thakkar, Xianwei Wang, Magomed Khaidakov, Yao Dai, Kuppan Gokulan, Jawahar L. Mehta & Kottayil I. Varughese. (2015) Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein. Scientific Reports 5:1.
Crossref
Crossref
Magda Gioia, Giulia Vindigni, Barbara Testa, Sofia Raniolo, Giovanni Francesco Fasciglione, Massimiliano Coletta & Silvia Biocca. (2015) Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells. PLOS ONE 10:10, pages e0141270.
Crossref
Crossref